Home NDC 40051-332 LEVETIRACETAM Extended-release
Product NDC 40051-332
11-digit product format 400510332
Labeler code 40051
Product ID 40051-332_7c902b2c-edf6-4dd0-923f-c38f2c621733
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name levetiracetam
Dosage form TABLET
Route ORAL
Labeler Lotus Pharmaceutical Co., Ltd. Nantou Plant
Application ANDA202095
Marketing category ANDA
Marketing start 2016-10-31
Marketing end 0000-00-00
Substance LEVETIRACETAM
Active strength 500 mg/1
Pharmacologic classes Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202095-001 LEVETIRACETAM LEVETIRACETAM 750MG TABLET, EXTENDED RELEASE / ORAL 2016-06-06 A202095-002 LEVETIRACETAM LEVETIRACETAM 500MG TABLET, EXTENDED RELEASE / ORAL 2016-06-06
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A202095-001 LEVETIRACETAM 750MG TABLET, EXTENDED RELEASE / ORAL 2016-06-06 a50c72e98297…2026-08-01 22:54:32 2026-06 A202095-002 LEVETIRACETAM 500MG TABLET, EXTENDED RELEASE / ORAL 2016-06-06 a50c72e98297…